Icariside I Analysis Service
- For solid samples: ≥ 200 mg, stored at -20°C.
- For liquid samples: ≥ 200 µL, stored at -20°C.
- Please provide detailed sample information, including the sample type, origin, and any specific requests for the analysis.
Icariside I is a flavonoid compound, known for its various beneficial effects on health such as anti-tumor, anti-osteoporosis and neuroprotective properties. These attributes make Icariside I a subject of interest in various research sectors, including pharmaceutical, nutraceutical, and cosmetic industries. However, due to its complex chemical structure, the analysis of Icariside I to determine its precise concentration is challenging.
Zhang, X. et al. Molecules. 2023.
Figure 1. The Pharmacological Activity of Icariside I
At MtoZ Biolabs, we utilize advanced mass spectrometry (MS) coupled with high performance liquid chromatography (HPLC-MS) to provide a comprehensive Icariside I Analysis Service. This technique enables accurate, sensitive, and specific detection and quantification of Icariside I in various sample types. Our HPLC-MS method uses an electrospray ionization (ESI) source to generate ions from the sample, which are then separated based on their mass-to-charge ratio. These separated ions are detected, and the resulting mass spectra are used to identify and quantify Icariside I.
Analysis Workflow
Service Advantages
1. Advanced Technology: We employ state-of-the-art HPLC-MS technology, ensuring high sensitivity and precision.
2. Experienced Team: Our team comprises experts in mass spectrometry and metabolomics, providing reliable and accurate results.
3. Detailed Report: We provide a comprehensive report detailing the analysis process and results, including raw and processed data, methodologies, and a thorough interpretation.
Applications
1. Icariside I Has Potential for Cancer Therapy by Blocking Tumor Immune Escape
Chen, G. et al. Biomed Pharmacother. 2022.
Figure 3. The Application of Icariside I in Cancer Therapy
2. Icariside I Ameliorates Estrogen Deficiency-Induced Osteoporosis via Simultaneous Regulation of Osteoblast and Osteoclast Differentiation
Chen, C. et al. ACS Pharmacol Transl Sci. 2023.
Figure 4. The Application of Icariside I in Alimorating Osteoporosis
Sample Submission Requirement
Deliverables
1. Experimental Procedures
2. Relevant Liquid Chromatography and Mass Spectrometry Parameters
3. Detailed Information on Icariside I
4. Raw Data
5. Custom Analysis Report
For further inquiries about our Icariside I Analysis Service, please do not hesitate to contact us. We are committed to providing you with high-quality services to meet your research demands.
How to order?